Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
2/7/2025 | $45.00 → $60.00 | Hold → Buy | TD Cowen |
1/21/2025 | $44.00 → $55.00 | Hold → Buy | Jefferies |
7/17/2024 | $43.00 → $40.00 | Underweight → Neutral | JP Morgan |
1/30/2024 | $40.00 | Neutral | Mizuho |
12/15/2023 | $38.00 | Outperform → Neutral | Robert W. Baird |
8/22/2023 | $40.00 | Neutral → Underweight | JP Morgan |
7/18/2023 | $46.00 → $42.00 | Buy → Neutral | Citigroup |
12/15/2022 | $55.00 → $50.00 | Overweight → Neutral | JP Morgan |
4 - Genpact LTD (0001398659) (Issuer)
4 - Genpact LTD (0001398659) (Issuer)
4 - Genpact LTD (0001398659) (Issuer)
DEFA14A - Genpact LTD (0001398659) (Filer)
DEF 14A - Genpact LTD (0001398659) (Filer)
10-K - Genpact LTD (0001398659) (Filer)
NEW YORK, April 10, 2025 /PRNewswire/ -- Genpact (NYSE:G) will report its financial results for the first quarter ended March 31, 2025, after the close of the U.S. financial markets on Wednesday, May 7, 2025. Following the release, Genpact's management team will host a conference call at 5:00 p.m. ET to discuss the company's performance. Participants are encouraged to register in advance to receive a dial-in number and unique PIN for seamless access. While early log-in is recommended, registration and access will be available throughout the call. A live webcast will be availab
Sustained recognition is a testament to Genpact's robust governance and ethical framework, powering responsible AI innovation NEW YORK, March 25, 2025 /PRNewswire/ -- Genpact (NYSE:G), an advanced technology services and solutions company that delivers lasting value for leading enterprises, today announced that it has been recognized as one of the 2025 World's Most Ethical Companies by Ethisphere, a global leader in defining and advancing the standards of ethical business practices. This marks the seventh time Genpact has received this prestigious honor, demonstrating its comm
~Focused on advanced products and financial discipline~ VANCOUVER, BC, Feb. 27, 2025 /CNW/ - Greenlane Renewables Inc. ("Greenlane" or the "Company") (TSX:GRN) (OTC:GRNWF) (FSE: 52G) today released a letter to shareholders from CEO, Brad Douville, providing an update on the Company's 2025 strategy. Dear Fellow Shareholders, As 2025 unfolds, in a time of significant political uncertainty, we remain resolute and committed to our mission of accelerating the energy transition. Our 2025 strategy involves advanced products, superior project execution, a strong parts and service plat
SC 13G/A - Genpact LTD (0001398659) (Subject)
SC 13G/A - Genpact LTD (0001398659) (Subject)
SC 13G/A - Genpact LTD (0001398659) (Subject)
NEW YORK, April 10, 2025 /PRNewswire/ -- Genpact (NYSE:G) will report its financial results for the first quarter ended March 31, 2025, after the close of the U.S. financial markets on Wednesday, May 7, 2025. Following the release, Genpact's management team will host a conference call at 5:00 p.m. ET to discuss the company's performance. Participants are encouraged to register in advance to receive a dial-in number and unique PIN for seamless access. While early log-in is recommended, registration and access will be available throughout the call. A live webcast will be availab
2024 Net Revenues of $4.77 billion, Up 6.5% (6.7% constant currency)1,22024 Data-Tech-AI Net Revenues of $2.23 billion, Up 6.9%1,2,3,42024 Digital Operations Net Revenues of $2.53 billion, Up 6.1% (6.5% constant currency)1,42024 Diluted EPS of $2.85, Down 16%; Adjusted Diluted EPS of $3.28, Up 10%5,6Increases Quarterly Dividend by 11% and Share Repurchase Authorization by $500 million NEW YORK, Feb. 6, 2025 /PRNewswire/ -- Genpact Limited (NYSE:G), a global advanced technology services and solutions company, today announced financial results for the fourth quarter and full year ended December 31, 2024.
NEW YORK, Jan. 13, 2025 /PRNewswire/ -- Genpact (NYSE:G) will report its financial results for the fourth quarter and full year ended December 31, 2024, after the close of the U.S. financial markets on Thursday, February 6, 2025. Following the release, Genpact's management team will host a conference call at 5:00 p.m. ET to discuss the company's performance. Participants are encouraged to register in advance to receive a dial-in number and unique PIN for seamless access. While early log-in is recommended, registration and access will be available throughout the call. A live we
Strategic business development leader Jinsook Han joins Genpact to spearhead strategy and M&A NEW YORK, Nov. 12, 2024 /PRNewswire/ -- Genpact (NYSE:G), a global professional services and solutions firm delivering outcomes that shape the future, today announced that Jinsook Han has joined the Company as Chief Strategy and Corporate Development Officer, effective immediately. She will be responsible for the company's strategy and investments, including ventures and acquisitions. Jinsook will report to President and CEO, Balkrishan "BK" Kalra. "Jinsook has that rare profile that
Seasoned technologist joins Genpact to accelerate AI and advanced technology roadmaps NEW YORK, Aug. 7, 2024 /PRNewswire/ -- Genpact (NYSE:G), a global professional services and solutions firm delivering outcomes that shape the future, today announced that Sanjeev Vohra has been named as the Company's first Chief Technology & Innovation Officer, effective immediately. Vohra will report to President and CEO, Balkrishan "BK" Kalra. Vohra, a seasoned leader and respected innovator, brings more than 30 years of technology, consulting and industry expertise to Genpact. His appointm
NEW YORK, Aug. 5, 2024 /PRNewswire/ -- Genpact (NYSE:G), a global professional services and solutions firm delivering outcomes that shape the future, today announced that Nicholas "Nick" Gangestad, Senior Vice President and Chief Financial Officer at Rockwell Automation, has been appointed to the Company's Board of Directors, effective August 12th, 2024. Gangestad will serve on the Board's Audit Committee. "Nick's deep expertise in finance and financial operations will not only provide additional insights to our Board, but will also give us valuable, first-hand perspectives on
TD Cowen upgraded Genpact from Hold to Buy and set a new price target of $60.00 from $45.00 previously
Jefferies upgraded Genpact from Hold to Buy and set a new price target of $55.00 from $44.00 previously
JP Morgan upgraded Genpact from Underweight to Neutral and set a new price target of $40.00 from $43.00 previously